Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 115,528 shares at $96.19 ($11.1M) on 2025-07-07, disclosed to the SEC on 2025-07-09.
Scheduled sale ($11.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.66 | 35,583 | $3.4M | 30.7% |
| 2 | $95.66 | 35,583 | $3.4M | 30.7% |
| 3 | $96.19 | 22,181 | $2.1M | 19.3% |
| 4 | $96.19 | 22,181 | $2.1M | 19.3% |
| Total | $95.86 avg | 115,528 | $11.1M | 100% |
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-23 | $12.0M | — | Filing → |